Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Cancer Research
|
November 1, 1989
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA
A Bodley, L F Liu, M Israel, et al.
Science (New York, N.Y.)
|
November 24, 1989
DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts
B C Giovanella, J S Stehlin, M E Wall, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II
R Silber, L F Liu, M Israel, et al.
Cancer Research
|
August 15, 1989
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues
Y H Hsiang, L F Liu, M E Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan
L Liebes, M Potmesil, T Kim, et al.
Blood
|
November 15, 1994
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs
R Silber, B Degar, D Costin, et al.
Cancer Research
|
June 15, 1988
Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II
M Potmesil, Y H Hsiang, L F Liu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Cancer Research
|
November 1, 1989
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA
A Bodley, L F Liu, M Israel, et al.
Science (New York, N.Y.)
|
November 24, 1989
DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts
B C Giovanella, J S Stehlin, M E Wall, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II
R Silber, L F Liu, M Israel, et al.
Cancer Research
|
August 15, 1989
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues
Y H Hsiang, L F Liu, M E Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan
L Liebes, M Potmesil, T Kim, et al.
Blood
|
November 15, 1994
Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs
R Silber, B Degar, D Costin, et al.
Cancer Research
|
June 15, 1988
Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II
M Potmesil, Y H Hsiang, L F Liu, et al.
Page
of 3